
    
      The overall goal of this study is to evaluate the efficacy of postpartum 24 hour oxytocin
      infusion as a prevention-oriented strategy to reduce blood loss in patients with
      pre-eclampsia (PE) in a blinded, placebo controlled, randomized controlled trial.
    
  